Is a one-size-fits-all approach to faecal immunochemical testing (FIT) still appropriate?
In this short podcast, Peter Vaughan-Shaw discusses a national study from Wales examining the increasing use of FIT in symptomatic patients and its implications for colorectal cancer detection. Between 2020 and 2024, FIT use increased approximately sevenfold, while its positive predictive value for colorectal cancer declined from 10.6% to 6.4%. The discussion explores differences in diagnostic performance by age and sex, and whether a more targeted approach to testing and referral could improve risk stratification and make better use of endoscopy resources.
Read the paper in BJS.
